Table: Oncolys Biopharma - 9-MTH parent results

Oncolys Biopharma

04/11/2022 06:00

Nov 4 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2022        Sep 30, 2021      Dec 31, 2022  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            784 mln             318 mln            1.00      
                                     (+53.3 pct)                    
  Operating     loss 937 mln        loss 963 mln        loss 1.60   
  Recurring     loss 854 mln        loss 976 mln        loss 1.60   
  Net           loss 835 mln        loss 979 mln        loss 1.60   
  EPS          loss 48.20 yen      loss 58.42 yen    loss 94.59 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T